These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Genetic Ablation of TASK-1 (Tandem of P Domains in a Weak Inward Rectifying K Schmidt C; Wiedmann F; Beyersdorf C; Zhao Z; El-Battrawy I; Lan H; Szabo G; Li X; Lang S; Korkmaz-Icöz S; Rapti K; Jungmann A; Ratte A; Müller OJ; Karck M; Seemann G; Akin I; Borggrefe M; Zhou XB; Katus HA; Thomas D Circ Arrhythm Electrophysiol; 2019 Sep; 12(9):e007465. PubMed ID: 31514528 [TBL] [Abstract][Full Text] [Related]
27. Randomized Study of Persistent Atrial Fibrillation Ablation: Ablate in Sinus Rhythm Versus Ablate Complex-Fractionated Atrial Electrograms in Atrial Fibrillation. Bassiouny M; Saliba W; Hussein A; Rickard J; Diab M; Aman W; Dresing T; Callahan T; Bhargava M; Martin DO; Shao M; Baranowski B; Tarakji K; Tchou PJ; Hakim A; Kanj M; Lindsay B; Wazni O Circ Arrhythm Electrophysiol; 2016 Feb; 9(2):e003596. PubMed ID: 26857909 [TBL] [Abstract][Full Text] [Related]
28. Angiotensin receptor blocker as adjunctive therapy for rhythm control in atrial fibrillation: results of the irbesartan-amiodarone trial. Madrid AH; Escobar C; Rebollo JM; Marín I; Bernal E; Nannini S; Limón L; Peng J; Moro C Card Electrophysiol Rev; 2003 Sep; 7(3):243-6. PubMed ID: 14739722 [TBL] [Abstract][Full Text] [Related]
29. Evaluation of practice patterns in the treatment of atrial fibrillation among the commercially insured. Liu J; Sylwestrzak G; Barron J; Rosenberg A; White J; Whitney J; Redberg R; Malenka D Curr Med Res Opin; 2014 Sep; 30(9):1707-13. PubMed ID: 24809834 [TBL] [Abstract][Full Text] [Related]
30. Demographic and clinical characteristics of patients with atrial fibrillation and cardioversion as planned therapeutic options in the International Registry on Cardioversion of Atrial Fibrillation RHYTHM-AF Polish substudy. Dąbrowski R; Opolski G; Włodarczyk P; Kiliszek M; Ponikowski P Kardiol Pol; 2014; 72(8):700-6. PubMed ID: 24671916 [TBL] [Abstract][Full Text] [Related]
31. Management of the older person with atrial fibrillation. Aronow WS J Am Geriatr Soc; 1999 Jun; 47(6):740-8. PubMed ID: 10366178 [TBL] [Abstract][Full Text] [Related]
32. The RACE study in perspective of randomized studies on management of persistent atrial fibrillation. Hagens VE; Van Gelder IC; Crijns HJ; Card Electrophysiol Rev; 2003 Jun; 7(2):118-21. PubMed ID: 14618033 [TBL] [Abstract][Full Text] [Related]
33. Targeted pharmacological reversal of electrical remodeling after cardioversion--rationale and design of the Flecainide Short-Long (Flec-SL) trial. Kirchhof P; Fetsch T; Hanrath P; Meinertz T; Steinbeck G; Lehmacher W; Breithardt G Am Heart J; 2005 Nov; 150(5):899. PubMed ID: 16290956 [TBL] [Abstract][Full Text] [Related]
34. Heart-team hybrid approach to persistent atrial fibrillation with dilated atria: the added value of continuous rhythm monitoring. Lapenna E; Cireddu M; Nisi T; Ruggeri S; Del Forno B; Monaco F; Bargagna M; D'Angelo G; Bisceglia C; Gulletta S; Agricola E; Castiglioni A; Alfieri O; De Bonis M; Della Bella P Eur J Cardiothorac Surg; 2021 Jul; 60(2):222-230. PubMed ID: 33760052 [TBL] [Abstract][Full Text] [Related]
35. Pharmacologic management of atrial fibrillation: established and emerging options. Kalus JS J Manag Care Pharm; 2009 Aug; 15(6 Suppl B):S10-8. PubMed ID: 19678722 [TBL] [Abstract][Full Text] [Related]
36. [Predictors of reversion to sinus rhythm previous to electrical cardioversion in patients with persistent atrial fibrillation treated with anti-arrhythmic drugs]. Viñolas X; Freire F; Romero-Menor C; Alegret JM Med Clin (Barc); 2013 Apr; 140(8):351-5. PubMed ID: 22982132 [TBL] [Abstract][Full Text] [Related]
37. [Atrial Fibrillation: How Important is Rhythm Control Therapy?]. Meyer C; Metzner A; Kirchhof P Dtsch Med Wochenschr; 2020 Apr; 145(8):543-549. PubMed ID: 32294780 [TBL] [Abstract][Full Text] [Related]
38. Antiarrhythmic Drug Therapy for Rhythm Control in Atrial Fibrillation. Waks JW; Zimetbaum P J Cardiovasc Pharmacol Ther; 2017 Jan; 22(1):3-19. PubMed ID: 27260643 [TBL] [Abstract][Full Text] [Related]
39. Efficacy of amiodarone for the prevention of atrial fibrillation recurrence after cardioversion. Istratoaie S; Sabin O; Vesa ŞC; Cismaru G; Donca VI; Buzoianu AD Cardiovasc J Afr; 2021 Nov-Dec 23; 32(6):327-338. PubMed ID: 33496719 [TBL] [Abstract][Full Text] [Related]
40. [Effect of diabetes mellitus in recovery and maintenance of sinus rhythm in patients with persistent atrial fibrillation]. Potpara T; Marinković-Erić J; Grujić M; Radojković-Cirović B; Vujisić-Tesić B; Petrović M Srp Arh Celok Lek; 2002; 130(5-6):189-92. PubMed ID: 12395441 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]